The Role of Dopamine Receptors in the Modulation of Mononuclear Phagocytes in Multiple Sclerosis

Objective . To study the role of D 1 DR and D 2 DR dopamine receptors in the production of interleukins (IL) IL-6 and IL-1β by monocytes and macrophages in patients with relapsing-remitting multiple sclerosis (MS). Materials and methods . Ten patients with relapsing-remitting MS and 10 healthy subje...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience and behavioral physiology Vol. 55; no. 1; pp. 133 - 138
Main Authors Lopatina, A. V., Sviridova, A. A., Belousova, O. O., Kuzmina, U. Sh, Melnikov, M. V.
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.01.2025
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0097-0549
1573-899X
DOI10.1007/s11055-025-01763-6

Cover

More Information
Summary:Objective . To study the role of D 1 DR and D 2 DR dopamine receptors in the production of interleukins (IL) IL-6 and IL-1β by monocytes and macrophages in patients with relapsing-remitting multiple sclerosis (MS). Materials and methods . Ten patients with relapsing-remitting MS and 10 healthy subjects were investigated. Levels of IL-6 and IL-1β production were assessed in culture supernatants obtained from CD14 + monocytes or macrophages stimulated with interferon-γ (IFN-γ) and lipopolysaccharide (LPS). The role of dopamine receptors in the regulation of CD14 + monocytes and macrophages was studied by incubating cell samples in the presence of specific D 1 DR or D 2 DR antagonists, after which they were stimulated with IFN-γ/LPS. Cytokine levels in cell culture supernatants were measured by enzyme-linked immunosorbent assay. Results . IL-6 and IL-1β production levels by CD14 + monocytes and macrophages were similar in the two groups. Blockade of D 1 DR suppressed cytokine production by both CD14 + monocytes and macrophages in both groups. In contrast, blockade of D 2 DR enhanced cytokine production by CD14 + monocytes and had no effect on macrophages in both groups. Conclusions . Targeting of dopamine receptors may provide an additional mechanism of immunoregulation in MS able to exert both pro- and anti-inflammatory effects on innate immune response cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0097-0549
1573-899X
DOI:10.1007/s11055-025-01763-6